Medical Robotic Systems Market Size, Share and Trends Analysis, By Product Type (Surgical Robots, Rehabilitation Robots, Non-invasive Radiosurgery Robots, Hospital & Pharmacy Automation Robots, Diagnostic Robots, Telemedicine Robots, and Others), By Component, By Automation Level, By End-Use, and By Region, Forecast 2025-2032

Medical Robotic Systems Market Overview and Key Insights:

The medical robotic systems market size reached USD 29.59 billion in 2024 and is expected to register a revenue CAGR of 16.8% during the forecast period. Robotic surgery is a contemporary surgical method that employs powerful robotic technologies to help surgeons perform complex surgical procedures with increased precision and control.

Market Drivers:

Rising incidence of chronic diseases is a key driver of revenue growth in the medical robotic systems market. According to the World Health Organization (WHO), every year, around 5 million people worldwide are diagnosed with epilepsy. In high-income countries, epilepsy is projected to affect 49 out of every 100,000 persons. In low- and middle-income nations, the figure can reach 139 per 100,000. This is most likely owing to an increased risk of endemic illnesses like malaria or neurocysticercosis. Moreover, In the United States, approximately one out of every 100 people have experienced a single unprovoked seizure or has been diagnosed with epilepsy. One in every 26 people will get epilepsy over their lives. People with specific conditions may be at an increased risk.

Technological advancement of neurological robots is another key driver driving the market growth over the forecasted period. On August 2024, Johnson & Johnson MedTech stated that DePuy Synthes, Johnson & Johnson’s Orthopaedics Company, has introduced a patented dual-use robotics and standalone navigation platform, developed in conjunction with eCential Robotics. The VELYS Active Robotic-Assisted System (VELYS SPINE) has acquired 510(k) clearance from the US Food and Drug Administration (FDA) and is indicated for use in planning and instrumenting spinal fusion surgeries in the cervical, thoracolumbar, and sacroiliac spines. The VELYS SPINE system is dual usage, which means it has both a standalone navigation and an active robotics platform, giving surgeons more freedom in their approach and plans.

Market Opportunity:

Increasing adoption of robotic-assisted surgery acts as an opportunity for the medical robotic systems market. Robotic surgery has seen widespread adoption, with several countries incorporating these devices into their healthcare infrastructure. Minimally invasive techniques cause less stress to the body, leading in shorter hospital stays, faster recovery durations, and less postoperative pain. The precision provided by medical robotic systems reduces the chance of problems, resulting in improved overall patient satisfaction and long-term health.

On June 2024, Smith+Nephew, a global medical technology business, has announced the debut of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, which offer an unequalled, individualized solution for surgeons and patients undergoing partial and total knee arthroplasty surgeries. It is only for use with the CORI Surgical System, the only orthopaedic robotic-assisted system that provides either intraoperative image-free or image-based registration, allowing the surgeon to decide whether to undertake a pre-operative MRI scan.

Recent Trends:

Emerging trends include Artificial Intelligence (AI) integration, miniaturization of robotic instruments, and integrated with telemedicine and remote surgery.

The incorporation of AI into robotic-assisted technologies advances the area by increasing the efficiency, accuracy, and user interaction with robotic systems. However, more study is needed to confirm the independent usefulness of AI in important surgical procedures. Increased autonomy in robotic surgery may result in more consistent outcomes, and new fields such as micro-robotics and telesurgery show great promise for future applications.

On April 2024, Medtronic has announced the release of 14 new AI-driven algorithms for surgical workflow, tool, and anatomy recognition on the Touch Surgery Performance Insights platform. These enhancements improve the platform’s capacity to transform surgical videos into useful insights after the procedure. Medtronic enables extensive study of surgical approaches, allowing doctors to improve their abilities and efficiency, learn from previous surgeries, and share with others. The enhanced analytics include a wide range of procedures, such as laparoscopic cholecystectomy, laparoscopic sleeve gastrectomy, and robotic-assisted hysterectomy, and provide unique insights into performance metrics, workflow, anatomy recognition, and instrument utilization.

Restraints & Challenges:

Surgical robots have grown in importance in the medical field as technology has advanced. However, the expense of obtaining a surgical robot remains a significant barrier for many medical organizations. A surgical robot typically costs between USD 1 million and USD 3 million, not counting installation, maintenance, and training. This price is obviously a significant investment for most healthcare companies.

Artificial intelligence (AI) has advanced significantly in several fields, with a growing impact on healthcare and medicine. Although AI has already been widely employed in medicine, the tight regulatory requirements for algorithms, devices, and robots used in medical applications make innovation in invasive procedures extremely difficult. The surgical field faces significant hurdles, as new technologies must meet high approval standards and require expensive, specialized hardware.

Product Type Segment Insights and Analysis:

Based on the product type, the medical robotic systems market is segmented into surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital & pharmacy automation robots, diagnostic robots, telemedicine robots, and others.

Surgical robots segment contributed the largest market share in 2024. The growing acceptance of robotic surgery may be attributed primarily to its obvious benefits to patients, surgeons, and hospital systems. Robotic surgery allows some procedures to be converted from open to laparoscopic, which often results in less discomfort, less bleeding, less time in the hospital, and faster recovery times.

Advances are being made to make robotic surgery instruments smaller and more flexible, allowing them to pass through blood vessels or natural orifices. Furthermore, artificial intelligence (AI) and automation will enable surgical robots to guide and evaluate surgeons, as well as execute a variety of surgical duties such as suture placement.

On March 2024, Intuitive, a global technological leader in minimally invasive treatment and a pioneer in robotic-assisted surgery, announced that the United States Food and Drug Administration (FDA) has granted 510(k) clearance to da Vinci 5, the company’s next-generation multiport robotic system. Da Vinci 5 is the most recent addition to the da Vinci family, which also includes the da Vinci X and da Vinci Xi multiport systems, as well as the da Vinci SP single-port system. These provide surgeons and hospitals with highly capable, proven solutions from Intuitive.

Telemedicine robots segment is expected to have the highest growth rate throughout the forecasted period. Robotic telemedicine offers remote patient monitoring, improves access to care without exposure to contagions, and is clever enough to learn and be taught how to take vital signs and send samples to the High-definition 3D visualization provides surgeons with a clearer perspective of the operating area, allowing them to make more informed decisions. Patients in remote locations can now obtain world-class surgical skills without having to travel, bridging the urban-rural healthcare divide.

On August 2024, VSee Health, Inc., a provider of comprehensive telehealth services that customize workflow streams and improve patient care, and Ava Robotics, a developer of intelligent robots for the workplace, have announced a collaboration to develop telepresence solutions for the inpatient intensive care market, including the creation of a VSee-powered Ava robot that allows providers to extend their reach and provide personalized care remotely. The Ava Robot will operate autonomously in the hospital intensive care unit (ICU), allowing competent physicians to be physically present at the point of patient care, interact with patients, confer with onsite staff, and make treatment decisions in real time.

Component Segment Insights and Analysis:

Based on the component, the medical robotic systems market is segmented into hardware, software, and services.

Hardware segment contributed the largest market share in 2024. Medical robotic systems are sophisticated tools that use hardware and software to aid in surgical procedures. These systems typically consist of robotic arms, customized end-effectors, control consoles, and imaging systems. Each component is essential for performing precise and less invasive procedures.

Components for many robotic applications must be engineered to fit into small places. Custom hardware design allows to produce tiny solutions that fit neatly inside the robot’s physical dimensions, ensuring that space is used efficiently. Custom hardware design makes it possible to integrate the latest technologies, such as advanced sensors, high-speed processors, and innovative materials. This integration allows companies to stay at the cutting edge of robotics technology, offering solutions that outperform standard hardware.

Software is expected to have the highest market growth rate throughout the forecasted period. In recent years, robotic modules with related algorithmic software have appeared in operating rooms. Furthermore, powerful computing methods enable robots to quickly process large amounts of data, assisting surgeons in their decision-making. Machine learning (ML) techniques have been important in allowing robots to learn from previous surgeries and continuously improve their performance. AI also improves surgical education by developing automated skills evaluation tools and providing intraoperative feedback. Experts address and debate the complicated ethical issues of robotic surgical AI as new developments emerge.

On November 2024, Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery, and vision solutions, announced that the FDA has approved the OTTAVA robotic surgical system investigational device exemption (IDE), allowing the clinical trial to begin at U.S. sites. Johnson & Johnson MedTech’s Polyphonic digital ecosystem will integrate the portfolio across world-class surgical devices, robots, and surgical software, taking use of Johnson & Johnson’s global scale.

End-Use Segment Insights and Analysis:

Based on the end-use, the medical robotic systems market is segmented into hospitals, Ambulatory Surgical Centers (ASCs), diagnostic centers, rehabilitation centers, pharmacy and compounding centers, research and academic institutions.

Hospitals segment contributed the largest market share in 2024. Robots are changing the face of ordinary surgery, particularly laparoscopic procedures, which are currently faster than traditional open abdominal surgeries. Surgeons primarily use them during surgeries to help patients recover from illnesses or injuries more quickly.

Medical robots can aid in minimally invasive surgeries, tailored and frequent monitoring of patients with chronic conditions, intelligent therapies, and social engagement for the elderly. Furthermore, as robots cut workloads, nurses and other caregivers may offer patients more empathy and human engagement, increasing long-term well-being. More than 76,000 surgeons around the world have trained on da Vinci systems and performed over 14 million surgical procedures using them.

Rehabilitation centers segment is expected to have the highest growth rate throughout the forecasted period. Stroke is a primary cause of death and long-term physical disability worldwide! Every year, it affects around fifteen million people worldwide, with five million dying and another five million becoming severely handicapped. The use of robots in neuro rehab is a cutting-edge treatment that employs robotic technology to enable rigorous, highly repetitive, adaptive, and measurable physical training. The use of advanced technologies such as robotics has transformed rehabilitation practices, with promising results for improving motor function and quality of life for patients with neurological impairments, including those recovering from stroke and spinal cord injury (SCI).

Geographical Outlook:

Medical robotic systems market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America Medical Robotic Systems Market:

North America is registered to have highest market share in medical robotic systems market in 2024. This is mainly due to the rising prevalence of chronic disorder, technological advancements, increasing healthcare expenditures, and a growing preference for minimally invasive procedures. According to the National Cancer Institute (NCI), In 2024, a projected 2 million new instances of cancer will be identified in the United States, with 611,720 deaths from the disease. Prostate, lung, and colorectal cancers will account for an estimated 48% of all malignancies diagnosed in males by 2024. Breast, lung, and colorectal cancers are the three most frequent among women, accounting for an anticipated 51% of all new cancer diagnoses in 2024.

On January 2025, Accuray Incorporated reported that the Radixact SynC System and CyberKnife S7 System have been approved by the Chinese National Medical Products Administration (NMPA). With these approvals, medical care providers in China may offer patients the most advanced Accuray radiation therapy solutions. The CyberKnife S7 System is the most recent CyberKnife platform, and the release of the Radixact SynC System represents the country’s first approval for ClearRT kVCT imaging and Synchrony real-time adaptive delivery technology on the Radixact system.

Asia Pacific Medical Robotic Systems Market:

Asia Pacific is registered the fastest growth rate during the forecasted period. This is mainly driven by rising incidence of chronic diseases, increasing adoption of robotic rehabilitation solutions, and rising demand for telemedicine and remote surgery. Brain tumours constitute a huge hazard in India, where healthcare difficulties are as diverse as the population. Each year, an estimated 40,000 new cases are diagnosed.

On June 2024, Meril, a prominent Indian medical device company, has launched its innovative surgical robotic system, MISSO, set to revolutionize knee replacement surgeries in India. Developed entirely in India, MISSO is designed to enhance surgical precision and reduce the dependency on costly imported robotic technologies. The launch of MISSO reflects India’s capabilities in developing high-end medical technologies. The system aligns with the country’s push towards achieving a more self-reliant healthcare sector.

Europe Medical Robotic Systems Market:

Europe is to register a considerable market share during the forecasted period. This is mainly driven by rising incidence of chronic diseases, increasing adoption of robotic imaging technologies. On February 2024, CMR Surgical (CMR) has introduced vLimeLite, an integrated fluorescence imaging system designed to visualise Indocyanine Green (ICG), providing surgeons with enhanced visualisation where required. With the latest Versius Plus surgical robot, surgeons can use vLimeLite to assess vessels, blood flow, tissue perfusion, and biliary anatomy. vLimeLite stands out in surgical robotics as it incorporates an ICG system with adjustable viewing options, offering full-colour or greyscale overlays. Additionally, it enables surgeons to select their preferred ICG colour, either green or cyan.

Competition Analysis:

The medical robotic systems market is characterized by a fragmented structure, with several players competing across various segments and regions. List of major players included in the medical robotic systems market report are:

• Intuitive Surgical, Inc.
• Medtronic plc
• Olympus Corporation
• Stryker Corporation
• Boston Scientific Corporation
• Asensus Surgical, Inc
• Smith & Nephew
• Titan Medical Inc.
• Avatera Medical GmbH
• Renishaw plc
• EndoMaster Pte Ltd
• Johnson & Johnson
• Brainlab AG
• CMR Surgical Ltd.
• Siemens Healthineers GmbH

Strategic Developments in Medical Robotic Systems Market:

• In November 2024, Rush University System for Health, a nationally recognized pioneer in high-quality care, announced the acquisition of Quantum Surgical’s Epione technology. Rush University Medical Center is one of only a few hospitals in the country—and the first in the Midwest—to use this groundbreaking technology. The Epione platform is cutting-edge robotic-assisted technology designed for interventional radiologists performing percutaneous ablations of abdominal malignancies, a minimally invasive procedure that is frequently employed with curative intent.
• In September 2024, Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced the closing of a USD 73 million Series B funding round led by Threshold Ventures, with participation from Lux Capital, PFM Health Sciences, and Fred Moll. The funding will help Mendaera scale robotics and AI across common medical operations.
• In June 2024, Zimmer Biomet Holdings, Inc., a worldwide medical technology pioneer, has announced a limited distribution partnership with THINK Surgical, Inc. for their wireless, handheld TMINI Miniature Robotic System for total knee arthroplasty. The cooperation will result in an exclusive offering that combines Zimmer Biomet technology with a bespoke TMINI robotic system. The TMINI system adds a portable robotic option to Zimmer Biomet’s comprehensive, flagship ROSA Robotics portfolio, allowing for precise implant placement according to a specified CT-based, three-dimensional surgical plan.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights Of The Medical Robotic Systems Market Report:

 The Medical Robotic Systems market report offers a detailed analysis of market size, including historical revenue (in USD Billion) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Product Type Outlook (Revenue, USD Billion; 2022-2032)
  • Surgical Robots
    • Laparoscopy Robots
    • Orthopedic Robots
    • Neurosurgical Robots
    • Cardiovascular Surgery Robots
    • Gynecological Surgery Robots
    • Urology Surgery Robots
    • Others
  • Rehabilitation Robots
    • Therapeutic Robots
    • Exoskeleton Robots
    • Prosthetic Robotics
    • Others
  • Non-invasive Radiosurgery Robots
    • CyberKnife
    • GammaKnife
    • Linear Accelerator Systems (LINAC)
    • Others
  • Hospital & Pharmacy Automation Robots
    • IV Robots
    • Pharmacy Dispensing Robots
    • Cart Transportation Robots
    • Automated Guided Vehicles (AGVs)
    • Others
  • Diagnostic Robots
  • Telemedicine Robots
  • Others
• Component Outlook (Revenue, USD Billion; 2022-2032)

• • Hardware
    • Sensors
    • Robotic Arms
    • Control Systems
    • Actuators
    • Others
  • Software
    • Operating Systems
    • Simulation Software
    • Data Analysis Platforms
    • Others
  • Services
    • Maintenance Services
    • Integration Services
    • Training Services
    • Consultancy Services
• Automation Level Outlook (Revenue, USD Billion; 2022-2032)

• • • Autonomous
    • Semi-Autonomous
    • Manual-Assisted
• End-Use Outlook (Revenue, USD Billion; 2022-2032)

• • • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Diagnostic Centers
    • Rehabilitation Centers
    • Pharmacy and Compounding Centers
    • Research and Academic Institutions
    • Others
• Regional Outlook (Revenue, USD Billion; 2022-2032)
• • • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Nordic Countries
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Oceania
      • ASEAN Countries
      • Rest of APAC
    • Latin America
      • Brazil
      • Rest of LATAM
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Israel
      • Turkey
      • Rest of MEA

Frequently Asked Questions (FAQ) about the Medical Robotic Systems market report